Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

21.4%

22 terminated/withdrawn out of 103 trials

Success Rate

77.1%

-9.4% vs industry average

Late-Stage Pipeline

46%

47 trials in Phase 3/4

Results Transparency

61%

45 of 74 completed trials have results

Key Signals

5 recruiting45 with results18 terminated4 withdrawn

Enrollment Performance

Analytics

Phase 3

43(44.8%)

Phase 1

32(33.3%)

Phase 2

16(16.7%)

Phase 4

4(4.2%)

N/A

1(1.0%)

96Total

Phase 3(43)

Phase 1(32)

Phase 2(16)

Phase 4(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (103)

Showing 20 of 103 trials

NCT03794388Phase 3Completed

Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery

Role: collaborator

NCT07347548Phase 1Active Not Recruiting

A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Role: lead

NCT07479745Phase 1Recruiting

Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019

Role: lead

NCT05840562Phase 3Recruiting

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Role: collaborator

NCT05449132Phase 3Completed

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

Role: lead

NCT05248386Phase 3Completed

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Role: lead

NCT05377489Phase 3Completed

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

Role: lead

NCT07289776Phase 1Recruiting

A First-in-human Trial of GRT7041 in Healthy Participants

Role: lead

NCT07317063Phase 1Completed

A Trial to Investigate Safety and Pharmacokinetics of GRT6019, Including Food Effect, in Healthy Male Participants

Role: lead

NCT03910738Phase 2Recruiting

TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

Role: collaborator

NCT03834922Completed

Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment

Role: collaborator

NCT06444919Phase 4Recruiting

Capsaicin in Digital Osteoarthritis Versus Control

Role: collaborator

NCT03765697Phase 3Completed

A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia

Role: lead

NCT03745404Phase 3Completed

A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)

Role: lead

NCT04001244Completed

Translational Research in Pelvic Pain

Role: collaborator

NCT04835779Unknown

Biometric and Biological Data for Diagnosis and Therapy of Pain Patients

Role: collaborator

NCT02880722Completed

Experience Sampling Method for Symptom Assessment in Irritable Bowel Syndrome

Role: collaborator

NCT03814993Completed

taPentadol cLinical prAcTice IN belgiUM

Role: collaborator

NCT02566564Phase 1Completed

Intra-articular Lopain (MTX-071) Phase I/IIa Study in Chronic Osteoarthritic Knee Joint Pain

Role: lead

NCT04184596Completed

Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)

Role: collaborator